- 1. *Difference
- [A change in or difference between; usually represented by the 4th letter of the greek alphabet. ( NCI )] (UMLS (HL7) C1705241) Change;
Delta;
Difference =Quantitative Concept =Kind of quantity;
| - 39. Diffuse Intraductal Papillomatosis
- (UMLS (NCI) C1377912) =Neoplastic Process
|
- 2. 2-(Difluoromethyl)-DL-ornithine
- [polyamine antagonist which reversibly inhibits DNA polymerase and irreversibly inhibits ornithine decarboxylase; used against bladder cancer, with potential applications in epilepsy and PCP withdrawal. ( CSP )] (UMLS (NCI) C0086156) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=[AN000] ANTINEOPLASTICS;
Antiprotozoal Agent;
fluoroaminoacid;
| - 40. Diffuse Large B-Cell Lymphoma
- [A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes. It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases. Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) ( NCI )] (UMLS (NCI) C0079744) =Neoplastic Process =histiocytic lymphoma;
Lymphoma, Undifferentiated;
Lymphoma, Diffuse;
Intermediate Grade Lymphoma |
- 3. 2-(Difluoromethyl)-dl-ornithine Hydrochloride, Monohydrate
- [The hydrochloride form of eflornithine, a difluoromethylated ornithine compound with antineoplastic activity. Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme required for polyamine biosynthesis, thereby inhibiting the formation and proliferation of tumor cells. Polyamines are involved in nucleosome oligomerization and DNA conformation, creating a chromatin environment that stimulates neoplastic transformation of cells. (NCI04) ( NCI )] (UMLS (NCI) C0282042) =Amino Acid, Peptide, or Protein; Pharmacologic Substance =Alpha-Difluoromethylornithine;
=EFLORNITHINE HYDROCHLORIDE 13.9 % | - 41. Diffuse Large B-Cell Lymphoma of the Thyroid
- [A diffuse large B-cell lymphoma primarily involving the thyroid gland. (NCI05) ( NCI )] (UMLS (NCI) C1336749) Diffuse Large B-Cell Lymphoma of the Thyroid Gland;
Diffuse Large B-Cell Lymphoma of Thyroid;
Diffuse Large B-Cell Lymphoma of Thyroid Gland;
Primary Thyroid Gland Diffuse Large B-Cell Lymphoma;
Thyroid Diffuse Large B-Cell Lymphoma;
Thyroid Gland Diffuse Large B-Cell Lymphoma =Neoplastic Process ;
|
- 4. Difenoxin
- (UMLS (NCI) C0057981) =Organic Chemical; Pharmacologic Substance ;
=[GA400] ANTIDIARRHEAL AGENTS;
DIPHENOXYLATE =4-Piperidinecarboxylic Acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-, Monohydrochloride;
| - 42. Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
- (UMLS (NCI) C1333293) Diffuse Large B-Cell Lymphoma PTLD =Neoplastic Process ;
|
- 5. DIFF CONNECT TIS DIS NEC
- [ ] (UMLS (ICD9CM) C0157748) =Disease or Syndrome
| - 43. Diffuse Large B-Cell Lymphoma Refractory
- [Diffuse large B-cell lymphoma that is resistant to treatment. ( NCI )] (UMLS (NCI) C0855112) Refractory Diffuse Large B-Cell Lymphoma;
=Neoplastic Process |
- 6. DIFF CONNECT TIS DIS NOS
- (UMLS (ICD9CM) C0041785) =Disease or Syndrome
| - 44. Diffuse Large B-Cell Lymphoma Stage I
- [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE).- 2003 ( NCI )] (UMLS (NCI) C0855113) Stage I Diffuse Large B-Cell Lymphoma;
=Neoplastic Process |
- 7. Diff-Quik Staining Method
- [Diff-Quick is an alcoholic, quick staining method for cytology. It consists of two solutions: an eosinophilic (red) solution and a basophilic (blue) stain. It is used for identifying squamous epithelial cells, inflammatory cells, yeast, bacteria, etc. ( NCI )] (UMLS (NCI) C0200973) =Laboratory Procedure
| - 45. Diffuse Large B-Cell Lymphoma Stage II
- [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). - 2003 ( NCI )] (UMLS (NCI) C0855114) Stage II Diffuse Large B-Cell Lymphoma;
=Neoplastic Process |
- 8. Differential
- (UMLS (HL7) C1549478) =Idea or Concept =Amount type;
| - 46. Diffuse Large B-Cell Lymphoma Stage III
- [Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). - 2003 ( NCI )] (UMLS (NCI) C0855115) Stage III Diffuse Large B-Cell Lymphoma;
=Neoplastic Process |
- 9. Differential Display
- [Variation of the polymerase chain reaction used to identify differentially expressed genes. mRNA from two different tissue samples is reverse transcribed, then amplified using short, intentionally nonspecific primers. The array of bands obtained from a series of such amplifications is run on a high resolution gel, and the array of bands compared with analogous arrays from different samples. Any bands unique to single samples are considered to be differentially expressed; they can be purified from the gel, and sequenced and used to clone the full-length cDNA. Similar in result to subtractive hybridization. (DCB-CB) ( NCI )] (UMLS (NCI) C0887824) Differential Display of mRNA =Laboratory Procedure; Molecular Biology Research Technique ;
| - 47. Diffuse Large B-Cell Lymphoma Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow or nodular involvement of the lung(s). - 2003 ( NCI )] (UMLS (NCI) C0855116) Stage IV Diffuse Large B-Cell Lymphoma;
=Neoplastic Process |
- 10. differential display technique
- [PCR based method to identify differentially expressed genes at mRNA level to analyze tissue specific gene expression and changes in the expression patterns; differences can be used for identification and isolation of the corresponding genes. ( CSP )] (UMLS (CSP) C0872030) =Research Activity ;
=genetic technique;
| - 48. Diffuse Large B-Cell Lymphoma with a Germinal Center B-Cell Expression Profile
- [A biologic subset of diffuse large B-cell lymphomas with a unique molecular signature or expression profile. It represents approximately 50% of diffuse large B-cell lymphomas, and is characterized by the expression of CD10, BCL-6, A-myb, and LMO2 genes, BCL-2 translocation, and c-REL amplification. Morphologically, the vast majority of these lymphomas are centroblastic and a small minority are immunoblastic (ratio20:1). Patients with this type of diffuse large B-cell lymphoma have a more favorable outcome, with a 5-year survival rate of 60% and a median survival of 10 years. — 2004 ( NCI )] (UMLS (NCI) C1333295) GCB-DLBCL;
Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma;
=Neoplastic Process ;
|
- 11. Differential light absorption chemical test
- [Chemical, Differential light absorption ( HL7V3.0 )] (UMLS (HL7) C1553113) =Laboratory Procedure =ObservationMethod;
| - 49. Diffuse Large Cell Type Lymphomatoid Papulosis
- [A variant of lymphomatoid papulosis characterized clinically by regressing skin papules, and morphologically by features resembling anaplastic large cell lymphoma. ( NCI )] (UMLS (NCI) C1333297) Diffuse Large Cell Type LyP;
Type C Lymphomatoid Papulosis;
Type C LyP =Neoplastic Process ;
|
- 12. differential semantics
- [measurement technique to assess subjective meanings of words; used in cross-cultural studies to study the development of meanings in children, and to assess psychotherapy. ( CSP )] (UMLS (CSP) C0036611) =Diagnostic Procedure; Intellectual Product =psycholinguistics;
| - 50. Diffuse Lipomatosis
- [A neoplastic process characterized by a diffuse poorly circumscribed overgrowth of adipose tissue. It has been associated with several genetic disorders and different clinical conditions such as liver disease, excessive alcohol intake, adrenocortical steroid therapy, and antiretroviral therapy. ( NCI )] (UMLS (NCI) C1333298) =Neoplastic Process ;
|
- 13. Differentially Expressed in Normal and Neoplastic Cells Protein
- [Encoded by MADD Gene, MADD Protein Isoforms A-G are expressed in adult testis, ovary, brain, heart, and fetal brain and kidney. The 1588-amino acid 176.6-kD isoform D is full-length. Most variants involve 2-4 stretches of 18-43 amino acids in the central region. Isoforms F and G have a different C-terminus. Containing a C-terminal death domain, RGD motif, and a leucine zipper-like motif, SER- and LEU-rich membrane-bound MADD adaptor protein interacts with TNFR1 death domain to propagate apoptotic signaling. MADD can activate ERK2 and JNK1 MAP kinases and induce phosphorylation of Phospholipase A2. MADD appears to link TNFR1 with MAP kinase activation and arachidonic acid release. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0538761) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 51. Diffuse Malignant Lymphoma
- (UMLS (NCI) C0334620) =Neoplastic Process
|
- 14. Differentiated Granulocytic Sarcoma
- [A granulocytic sarcoma composed of promyelocytes and more mature neutrophils (WHO 2001). —2003 ( NCI )] (UMLS (NCI) C1333287) =Neoplastic Process ;
| - 52. Diffuse Malignant Mesothelioma
- (UMLS (NCI) C0392400) =Neoplastic Process ;
|
- 15. Differentiated Retinoblastoma
- (UMLS (NCI) C0334600) =Neoplastic Process
| - 53. Diffuse Melanocytosis
- [Diffuse Melanocytosis is a diffuse or multifocal proliferation of uniform nevoid polygonal cells in the leptomeninges. Cells may spread into the Virchow-Robin spaces without frank invasion of the brain. Diffuse Melanocytosis carries a poor prognosis even in the absence of histologic malignancy. (WHO) ( NCI )] (UMLS (NCI) C1266112) Diffuse Melanosis;
Diffuse Meningeal Melanocytosis;
=Neoplastic Process |
- 16. Differentiated Thyroid Cancer
- [An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation. According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma. (NCI05) ( NCI )] (UMLS (NCI) C1337013) Differentiated Thyroid Carcinoma;
Differentiated Thyroid Gland Carcinoma;
Thyroid Gland Differentiated Carcinoma;
Thyroid Gland Well Differentiated Carcinoma;
Well Differentiated Thyroid Carcinoma;
Well Differentiated Thyroid Gland Carcinoma;
Well-differentiated Thyroid Cancer =Neoplastic Process ;
| - 54. Diffuse Mixed Cell Lymphoma
- (UMLS (NCI) C0079757) =Neoplastic Process =Lymphoma, Mixed-Cell;
Lymphoma, Diffuse;
Intermediate Grade Lymphoma;
|
- 17. Differentiated Vulvar Intraepithelial Neoplasia
- (UMLS (NCI) C1335968) dVIN;
d-VIN;
Simplex (Differentiated) Vulvar Intraepithelial Neoplasia;
SxVIN =Neoplastic Process ;
| - 55. Diffuse Neurofibroma
- (UMLS (NCI) C0432361) =Neoplastic Process
|
- 18. differentiation antigen
- [antigens normally only seen at particular phases of differentiation of a cell type. ( CSP )] (UMLS (CSP) C0003324) =Immunologic Factor
| - 56. diffuse optical tomography
- [ ] (UMLS (CSP) C1328868) =Diagnostic Procedure; ;
|
- 19. Differentiation Therapy
- [Drug therapy aimed at forcing cancer cells to resume the process of maturation and therefore to induce tumor to a more differentiated, less aggressive state. Differentiation therapy restrains cancer cells growth and facilitates the application of more conventional therapies. ( NCI )] (UMLS (NCI) C0281375) =Therapeutic or Preventive Procedure ;
| - 57. Diffuse Palmoplantar Keratoderma
- [An autosomal dominant disorder characterized by a widely distributed, well-demarcated hyperkeratosis of the palms and soles. There is more than one genotypically distinct form, each of which is clinically similar but histologically distinguishable. Diffuse palmoplantar keratoderma is distinct from palmoplantar keratoderma (KERATODERMA, PALMOPLANTAR), as the former exhibits autosomal dominant inheritance and hyperhidrosis is frequently present. ( MSH )] (UMLS (NCI) C0022584) =Disease or Syndrome ;
=Keratoderma, Palmoplantar;
|
- 20. Difficulty
- [Something not easily done, accomplished, comprehended, or solved. ( NCI )] (UMLS (NCI) C1299586) =Finding
| - 58. Diffuse Pattern
- [A morphologic architectural pattern in which a cellular population is distributed in a relatively uniform fashion throughout a specified tissue area; not focal. ( NCI )] (UMLS (NCI) C1333299) =Finding ;
|
- 21. Diffimicin
- [A member of the narrow-spectrum, 18-membered macrolide antibiotics (tiacumicins) isolated from cultures of Dactylosporangium aurantiacum subsp. hamdenensis and Actinoplanes deccanensis with potential antibacterial activity. Although the exact mechanism of action through which tiacumicin B exerts its effect has yet to be fully elucidated, this antibiotic may act by binding to and inhibiting bacterial DNA-dependent RNA polymerase, thereby inhibiting the initiation of bacterial RNA synthesis. After oral administration, tiacumicin B is not absorbed and exerts its effect locally in the intestines. In addition, this agent appears to be active against pathogenic gram-positive bacteria, such as clostridia, enterococci and staphylococci, but is not active against other intestinal bacteria, thereby allowing the normal gut flora to survive and exert its protective effect. ( NCI )] (UMLS (NCI) C0145907) =Carbohydrate
| - 59. Diffuse Peritoneal Leiomyomatosis
- [A condition characterized by the presence of numerous small benign smooth muscle neoplasms growing throughout the female pelvis. It is usually associated with pregnancy. ( NCI )] (UMLS (NCI) C0267785) =Neoplastic Process ;
|
- 22. diffraction of light
- [ ] (UMLS (CSP) C0599027) =Natural Phenomenon or Process ;
| - 60. Diffuse Pulmonary Fibrosis
- (UMLS (NCI) C0865849) =Disease or Syndrome ;
|
- 23. DIFFUS INTERSTIT KERATIT
- [ ] (UMLS (ICD9CM) C0155089) =Disease or Syndrome
| - 61. Diffuse Retinoblastoma
- (UMLS (NCI) C1266185) =Neoplastic Process
|
- 24. diffuse
- [Widely spread; not localized or confined. ( NCI )] (UMLS (NCI) C0205219) =Qualitative Concept
| - 62. Diffuse secondary atrophy of choroid
- [ ] (UMLS (ICD9CM) C0154892) =Disease or Syndrome
|
- 25. Diffuse Astrocytoma
- [A low-grade (WHO grade II) astrocytic neoplasm. It is characterized by a high degree of cellular differentiation, slow growth, and diffuse infiltration of neighboring brain structures. These lesions typically affect young adults and have an intrinsic tendency for malignant progression to anaplastic astrocytoma and, ultimately, glioblastoma. According to the prevailing cells type, three major variants can be distinguished: Fibrillary Astrocytoma, Gemistocytic Astrocytoma, and Protoplasmic Astrocytoma. (Adapted from WHO) ( NCI )] (UMLS (NCI) C0280785) =Neoplastic Process
| - 63. diffuse systemic sclerosis
- [A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability. ( MSH )] (UMLS (CSP) C1258104) =Disease or Syndrome ;
|
- 26. Diffuse C-Cell Hyperplasia
- (UMLS (NCI) C0342190) =Disease or Syndrome ;
| - 64. Diffuse Type Adenocarcinoma
- [An adenocarcinoma characterized by the presence of a diffuse cellular infiltrate which is composed of poorly cohesive cells with minimal or no glandular formations. Representative example is the gastric diffuse adenocarcinoma. ( NCI )] (UMLS (NCI) C0334280) =Neoplastic Process
|
- 27. Diffuse Cellular Infiltrate
- (UMLS (NCI) C1333289) =Finding ;
| - 65. diffusion
- [tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space; a major mechanism of biological transport. ( CSP )] (UMLS (CSP) C0012222) =Natural Phenomenon or Process =Physical Phenomenon;
|
- 28. diffuse cerebral sclerosis
- [A rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers' Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. (From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13(4-5):267-73) ( MSH )] (UMLS (CSP) C0007795) =Disease or Syndrome ;
=Brain Diseases;
Demyelinating Autoimmune Diseases, CNS | - 66. Diffusion
- [Diffusion ( HL7V3.0 )] (UMLS (HL7) C1696141) =Functional Concept =RouteByMethod;
=Diffusion, extracorporeal;
Diffusion, hemodialysis;
Diffusion, transdermal;
|
- 29. DIFFUSE CHOLESTEATOSIS
- (UMLS (ICD9CM) C0155491) =Disease or Syndrome ;
| - 67. diffusion magnetic resonance imaging
- [MRI method that measure the diffusion of water in the tissue, rather than the content of water as measured in conventional MRI. ( NCI )] (UMLS (CSP) C1136216) Diffusion MRI;
=Diagnostic Procedure =magnetic resonance imaging;
|
- 30. Diffuse Cutaneous Mastocytosis
- [A variant of cutaneous mastocytosis which is seen almost exclusively in children. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C0024901) =Disease or Syndrome
| - 68. diffusion weighted imaging
- [ ] (UMLS (CSP) C0598801) =Diagnostic Procedure ;
|
- 31. Diffuse Dysplasia
- (UMLS (NCI) C0522619) =Cell or Molecular Dysfunction
| - 69. Diffusion, extracorporeal
- [Diffusion, extracorporeal ( HL7V3.0 )] (UMLS (HL7) C1552101) =Functional Concept =Diffusion;
ExtracorporealCirculationRoute |
- 32. Diffuse Follicle Centre Lymphoma
- (UMLS (NCI) C1333290) Follicle Centre Lymphoma Diffuse =Neoplastic Process ;
| - 70. Diffusion, hemodialysis
- [Diffusion, hemodialysis ( HL7V3.0 )] (UMLS (HL7) C1553207) =Functional Concept =Diffusion;
IntravascularRoute |
- 33. Diffuse Giant Cell Neoplasm of Tendon Sheath
- [A locally aggressive, diffusely infiltrating tumor, arising in the tendon sheath. It is composed of synovial-like mononuclear cells, hemosiderin-laden macrophages, foam cells, and inflammatory cells. Multinucleated osteoclast-like giant cells are usually present, although in a minority of cases they may be absent or rare. It predominantly affects young adults. Symptoms include joint swelling, pain, and joint effusion. ( NCI )] (UMLS (NCI) C0039106) =Disease or Syndrome =synovitis;
| - 71. Diffusion, transdermal
- [Diffusion, transdermal ( HL7V3.0 )] (UMLS (HL7) C1554960) =Functional Concept =Cutaneous Route of Administration;
Diffusion |
- 34. Diffuse Glomerulonephritis
- (UMLS (NCI) C0859036) =Disease or Syndrome
| - 72. Difloxacin
- (UMLS (NCI) C0057993) =Organic Chemical; Antibiotic ;
|
- 35. Diffuse Hyperplasia of Bronchus-Associated Lymphoid Tissue
- [Mitelman_Code: 201 ( NCI )] (UMLS (NCI) C0264511) =Disease or Syndrome
| - 73. diflucan
- [ ] (UMLS (CSP) C0699601) =Organic Chemical; Pharmacologic Substance ;
|
- 36. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia
- (UMLS (NCI) C1333291) DIPNECH;
DIP-NECH;
=Disease or Syndrome ;
| - 74. DIFLUCORTOLONE PIVALATE
- (UMLS (NCI) C0770953) =Organic Chemical; Pharmacologic Substance ;
|
- 37. Diffuse Infiltrative Lymphocytosis Syndrome
- [This is usually an oligoclonal CD8+ lymphocytic infiltration of various organs. ( NCI )] (UMLS (NCI) C1333292) =Disease or Syndrome ;
| - 75. DIFLUMIDONE
- (UMLS (NCI) C0057995) =Organic Chemical; Pharmacologic Substance ;
|
- 38. diffuse interstitial pulmonary fibrosis
- [chronic inflammation and progressive fibrosis of the pulmonary alveolar walls with steady progressive dyspnea; finally, resulting in death from lack of oxygen or right heart failure. ( CSP )] (UMLS (CSP) C0085786) =Disease or Syndrome ;
=pulmonary fibrosis/granuloma;
| |
home
